Curaleaf Holdings Inc banner

Curaleaf Holdings Inc
TSX:CURA

Watchlist Manager
Curaleaf Holdings Inc Logo
Curaleaf Holdings Inc
TSX:CURA
Watchlist
Price: 5.24 CAD 25.66% Market Closed
Market Cap: CA$4.1B

Curaleaf Holdings Inc
Accrued Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Curaleaf Holdings Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Curaleaf Holdings Inc
TSX:CURA
Accrued Liabilities
$128.2m
CAGR 3-Years
2%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Accrued Liabilities
$32.3B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
10%
Bristol-Myers Squibb Co
NYSE:BMY
Accrued Liabilities
$13.1B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Accrued Liabilities
$3.6B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
4%
Merck & Co Inc
NYSE:MRK
Accrued Liabilities
$14.4B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Accrued Liabilities
$19.8B
CAGR 3-Years
26%
CAGR 5-Years
24%
CAGR 10-Years
19%
No Stocks Found

Curaleaf Holdings Inc
Glance View

Curaleaf Holdings Inc., a prominent player in the burgeoning cannabis market, has carved out a significant niche for itself by fully integrating its operations from cultivation to distribution. Founded in 2010, the Massachusetts-based company has rapidly grown to become one of the largest cannabis retailers in the United States. With a keen eye on the complex regulatory landscape, Curaleaf has strategically expanded its footprint across multiple states, adapting to various state laws and regulations. Their operational strategy hinges on vertical integration, meaning they control every stage of the cannabis supply chain. This allows Curaleaf not only to maintain high product quality and consistency but also to maximize margins by reducing costs and gaining efficiencies at all levels of production and retailing. Generating revenue through a combination of wholesale and retail sales, Curaleaf has established a range of products including cannabis flower, oils, edibles, and topical treatments, catering to both medical and recreational customers. The company's retail outlets, spanning across multiple states, are crucial in driving sales, where knowledgeable staff guide customers through intricate product offerings aimed at satisfying diverse consumer needs. Meanwhile, Curaleaf’s wholesale division supplies products to other retail outlets, expanding its market reach and solidifying its brand presence. The synergy between its retail prowess and wholesale operations has allowed Curaleaf to sustain steady revenue growth, positioning it well in a highly competitive and rapidly evolving industry.

CURA Intrinsic Value
2.74 CAD
Overvaluation 48%
Intrinsic Value
Price CA$5.24

See Also

What is Curaleaf Holdings Inc's Accrued Liabilities?
Accrued Liabilities
128.2m USD

Based on the financial report for Dec 31, 2025, Curaleaf Holdings Inc's Accrued Liabilities amounts to 128.2m USD.

What is Curaleaf Holdings Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
17%

Over the last year, the Accrued Liabilities growth was 9%. The average annual Accrued Liabilities growth rates for Curaleaf Holdings Inc have been 2% over the past three years , 17% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett